Mostrar el registro sencillo del ítem
The Latest Evidence in the Neuroscience of Solvent Misuse: An Article Written for Service Providers
dc.creator | Cruz, Silvia L. | |
dc.date.accessioned | 2017-06-29T06:09:29Z | |
dc.date.available | 2017-06-29T06:09:29Z | |
dc.date.issued | 2011 | es_ES |
dc.identifier | 705 | es_ES |
dc.identifier.issn | 1082-6084 | es_ES |
dc.identifier.uri | http://repositorio.inprf.gob.mx/handle/123456789/5389 | |
dc.identifier.uri | https://doi.org/10.3109/10826084.2011.580215 | es_ES |
dc.description.abstract | This work reviews preclinical and clinical studies published during the past two decades on the cellular and behavioral effects of commonly misused solvents. In animals, acute solvent exposure produces motor impairment and antidepressant- and anxiolytic-like effects. Human intoxication from misusing solvents is similar to that of ethanol; however, hallucinations and sudden sniffing death may occur at high solvent concentrations. Among chronic misusers, there is evidence of impaired memory, increased prevalence of psychiatric disorders, and neurological damage. Solvents facilitate inhibitory neurotransmission and block excitatory mechanisms. Toluene, in particular, increases brain dopamine levels and its effects occur at concentrations that do not dissolve cell membranes; therefore, neuronal damage is not an immediate, unavoidable consequence of solvent misuse | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Informa Healthcare, Telephone House, 69-77 Paul Street, London EC2A 4LQ, England | es_ES |
dc.relation | 46 (1) 62-67 p. | es_ES |
dc.relation | versión del editor | es_ES |
dc.rights | acceso cerrado | es_ES |
dc.title | The Latest Evidence in the Neuroscience of Solvent Misuse: An Article Written for Service Providers | es_ES |
dc.type | article | es_ES |
dc.contributor.affiliation | CINVESTAV, Dept Farmacobiol, Mexico City 14000, DF, Mexico | es_ES |
dc.contributor.email | slcruz@cinvestav.mx | es_ES |
dc.relation.jnabreviado | SUBST USE MISUSE | es_ES |
dc.relation.journal | Substance use & misuse | es_ES |
dc.identifier.place | Londres | es_ES |
dc.date.published | 2011 | es_ES |
dc.identifier.organizacion | Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz | es_ES |
dc.identifier.doi | 10.3109/10826084.2011.580215 | es_ES |
dc.subject.meshm | Inhalant abuse | es_ES |
dc.subject.meshm | Xenopus oocytes | es_ES |
dc.subject.meshm | Animals-Models | es_ES |
dc.subject.meshm | Toluene | es_ES |
dc.subject.meshm | Mice | es_ES |
dc.subject.meshm | Anesthetics | es_ES |
dc.subject.meshm | Inhibition | es_ES |
dc.subject.meshm | Methyl-D-Aspartate | es_ES |
dc.subject.meshm | Exposure | es_ES |
dc.subject.meshm | Youth | es_ES |
dc.subject.kw | Inhalantes | es_ES |
dc.subject.kw | Solventes | es_ES |
dc.subject.kw | Tolueno | es_ES |
dc.subject.kw | Efectos agudos | es_ES |
dc.subject.kw | Efectos crónicos | es_ES |
dc.subject.kw | Mecanismos de acción | es_ES |
dc.subject.kw | Receptores | es_ES |
dc.subject.ko | Inhalants | es_ES |
dc.subject.ko | Solvents | es_ES |
dc.subject.ko | Toluene | es_ES |
dc.subject.ko | Acute effects | es_ES |
dc.subject.ko | Chronic effects | es_ES |
dc.subject.ko | Mechanisms of action | es_ES |
dc.subject.ko | Receptors | es_ES |
Ficheros en el ítem
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |